IGIS Asia Investment Management Partners with CHA Bio Group to Launch Life Science Real Estate Platform JV
SEOUL, KOREA - Media OutReach - 16 February 2023 - IGIS Asia Investment Management ("IGIS"),…
3 years ago
WNS Announces Departure of COO, New Organizational Structure
NEW YORK & MUMBAI, India--(BUSINESS WIRE)--$WNS #BPM--WNS (Holdings) Limited (NYSE: WNS), a leading provider of…
3 years ago
RPT Realty Reports Fourth Quarter and Full Year 2022 Results; Provides Initial 2023 Guidance; Increases Quarterly Common Dividend
Financial Highlights Net income (loss) attributable to common shareholders for the fourth quarter 2022 of…
3 years ago
Corporación América Airports S.A. Reports January 2023 Passenger Traffic
Total passenger traffic up 42.7% YoY reaching 90% of pre-pandemic levels; Armenia and Ecuador above…
3 years ago
Triton Digital Releases the New Zealand Podcast Ranker for January 2023
AUCKLAND, New Zealand--(BUSINESS WIRE)--Triton Digital®, the global technology and services leader to the digital audio,…
3 years ago
Introba Selects Living Systems as Platform for Transforming the Built Environment
ST. LOUIS--(BUSINESS WIRE)--#LivingSystems--Introba, one of the world’s largest building engineering and consulting firms (formerly Integral…
3 years ago
AM Best Places Credit Ratings of Fubon Insurance Vietnam Co., Ltd. Under Review With Negative Implications
SINGAPORE--(BUSINESS WIRE)--#insurance--AM Best has placed under review with negative implications the Financial Strength Rating (FSR)…
3 years ago
AM Best Places Credit Ratings of Fubon Insurance Vietnam Co., Ltd. Under Review With Negative Implications
SINGAPORE--(BUSINESS WIRE)--#insurance--AM Best has placed under review with negative implications the Financial Strength Rating (FSR)…
3 years ago
AM Best Places Credit Ratings of Fubon Insurance Vietnam Co., Ltd. Under Review With Negative Implications
SINGAPORE--(BUSINESS WIRE)--#insurance--AM Best has placed under review with negative implications the Financial Strength Rating (FSR)…
3 years ago
Poxel Reports Cash and Revenue for the Full Year 2022 and Provides Corporate Update
TWYMEEG® (Imeglimin) recent growth trajectory confirmed with a 90% increase in sales in Japan over…
3 years ago